Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Insulet (PODD)
:PODD
PODD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$160.19 - $289.46
Previous CloseN/A
Volume86.50K
Average Volume (3M)552.47K
Market Cap
$19.69B
Enterprise Value$17.71B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)48.2
Beta1.28
Next Earnings
May 01, 2025EPS Estimate
0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.88
Shares Outstanding70,144,775
10 Day Avg. Volume575,425
30 Day Avg. Volume552,469
Standard Deviation0.11
R-Squared0.32
Alpha-0.00233
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.03
Price to Cash Flow (P/CF)50.50
P/FCF Ratio71.70
Enterprise Value/Market Cap0.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit15.27
Enterprise Value/Ebitda41.30
Forecast
1Y Price Target
$314.00Price Target Upside8.92% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
---
Bulls Say, Bears Say
Bulls Say
Legal VictoryThe U.S. district court delivered a jury trial verdict in favor of PODD against EOFlow, awarding $452M in total damages to PODD.
Product ExpansionPODD has multiple drivers lined up for 2025, including a new US label for type 2 and the planned expansion of O5 into 10 more countries in Europe.
Bears Say
Competitive PressureCompetitor T2 pump approvals are expected to follow, which could lead to competitive pressure in the T2 segment.
---
Ownership Overview
0.34% Insiders
41.77% Mutual Funds
27.70% Other Institutional Investors
4.65% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PODD FAQ
What was Insulet’s price range in the past 12 months?
Insulet lowest stock price was $160.19 and its highest was $289.46 in the past 12 months.
What is Insulet’s market cap?
Insulet’s market cap is $19.69B.
When is Insulet’s upcoming earnings report date?
Insulet’s upcoming earnings report date is May 01, 2025 which is in 69 days.
How were Insulet’s earnings last quarter?
Insulet released its earnings results on Feb 20, 2025. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.004 by $0.146.
Is Insulet overvalued?
According to Wall Street analysts Insulet’s price is currently Undervalued.
Does Insulet pay dividends?
Insulet does not currently pay dividends.
What is Insulet’s EPS estimate?
Insulet’s EPS estimate is 0.78.
How many shares outstanding does Insulet have?
Insulet has 70,144,775 shares outstanding.
What happened to Insulet’s price movement after its last earnings report?
Insulet reported an EPS of $1.15 in its last earnings report, beating expectations of $1.004. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Insulet?
Currently, no hedge funds are holding shares in PODD
---
Insulet Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$314.00 (8.92% Upside)
$314.00 (8.92% Upside)
Blogger Sentiment
Bullish
PODD Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 230.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $139.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 6.6%
Last 30 Days ▲ 6.6%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
49.98%
12-Months-Change
Fundamentals
Return on Equity
48.79%
Trailing 12-Months
Asset Growth
22.60%
Trailing 12-Months
Company Description
Insulet
Insulet Corp. is a medical device company. The firm engages in the development, manufacture and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.
---
PODD Company Deck
---
PODD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for Insulet with significant achievements in revenue growth and market expansion, particularly with the Omnipod 5's entry into the type 2 diabetes market. Despite some challenges in U.S. revenue growth and anticipated retention issues in certain type 2 segments, the company's strategic advancements and international success position it well for continued growth.Read More>---
PODD Revenue Breakdown
75.84% U.S.
24.16% International
---
PODD Stock 12 Month Forecast
Average Price Target
$314.00
▲(8.92% Upside)
Technical Analysis
Best Analysts Covering PODD
1 Year
1 Year Success Rate
13/14 ratings generated profit
1 Year Average Return
+33.21%
assigned a buy rating 2 months ago
Copying Matthew Taylor's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +33.21% per trade.
---